Similarity and Robustness of PET and SPECT Binding Parameters for Benzodiazepine Receptors
Open Access
- 1 November 2000
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 20 (11) , 1587-1603
- https://doi.org/10.1097/00004647-200011000-00009
Abstract
The single photon emission computed tomography (SPECT) radiotracer [123I]iomazenil is used to assess benzodiazepine receptor binding parameters. These measurements are relative indices of benzodiazepine receptor concentration (B′max). To evaluate the ability of such indices in accurately accessing the B′max the authors compared them with absolute values of B′max, measured using positron emission tomography (PET). The authors performed SPECT, PET, and magnetic resonance imaging (MRI) studies on a group composed of seven subjects. For SPECT studies, the authors administered a single injection of [123I]iomazenil and estimated the total and specific distribution volumes (DVT SPECT, DVS SPECT) and the binding potential (BP) using unconstrained (BPSPECT) and constrained (BPC SPECT) compartmental models. For PET studies, the authors used a multiinjection approach with [11C]flumazenil and unlabeled flumazenil to estimate absolute values of receptor concentration, B′max, and some other binding parameters. The authors studied the correlation of different binding parameters with B′max. To study the robustness of the binding parameter measurements at the pixel level, the authors applied a wavelet-based filter to improve signal-to-noise ratio of time-concentration curves, and the calculated kinetic parameters were used to build up parametric images. For PET data, the B′max and the DVPET were highly correlated ( r = 0.988). This confirms that it is possible to use the DVPET to access benzodiazepine receptor density. For SPECT data, the correlation between DVSPECT estimated using a two-and three-compartment model was also high ( r = 0.999). The DVT SPECT and BPC SPECT parameters estimated with a constrained three-compartment model or the DVT″SPECT parameter estimated with a two-compartment model were also highly correlated to the B′max parameter estimated with PET. Finally, the robustness of the binding parameters allowed the authors to build pixel-by-pixel parametric images using SPECT data.Keywords
This publication has 33 references indexed in Scilit:
- Wavelet Analysis of Dynamic PET Data: Application to the Parametric Imaging of Benzodiazepine Receptor ConcentrationNeuroImage, 2000
- Altered In Vitro and In Vivo Flumazenil Binding in Human Epileptogenic NeocortexJournal of Cerebral Blood Flow & Metabolism, 1999
- Carbon-11 and iodine-123 labelled iomazenil: a direct PET-SPET comparisonEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Quantification of Benzodiazepine Receptors in Human Brain Using PET, [11C]Flumazenil, and a Single-Experiment ProtocolJournal of Cerebral Blood Flow & Metabolism, 1995
- Pharmacokinetics of the SPECT benzodiazepine receptor radioligand [123I]iomazenil in human and non-human primatesInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1992
- A comparison of methods for the separation of [11C]Ro 15-1788 (flumazenil) from its metabolites in the blood of rabbits, baboons and humansInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1991
- Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission TomographyJournal of Cerebral Blood Flow & Metabolism, 1991
- Plasma pharmacokinetics and metabolism of the benzodiazepine antagonist [11C] Ro 15-1788 (flumazenil) in baboon and human during positron emission tomography studiesEuropean Journal of Drug Metabolism and Pharmacokinetics, 1991
- Benzodiazepine receptor binding with [3H]-Ro 15-1788Life Sciences, 1985
- Kinetics of in vivo binding of antagonist to muscarinic cholinergic receptor in the human heart studied by positron emission tomographyLife Sciences, 1984